Assam Chemical & Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 13-12-2024
- Paid Up Capital ₹ 2.68 M
as on 13-12-2024
- Company Age 78 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.40 M
as on 13-12-2024
- Revenue 14.65%
(FY 2022)
- Profit 24.26%
(FY 2022)
- Ebitda 27.40%
(FY 2022)
- Net Worth 11.00%
(FY 2022)
- Total Assets 12.04%
(FY 2022)
About Assam Chemical & Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.68 M.
The company currently has active open charges totaling ₹5.40 M.
Madhab Das, Jaydeep Bhuyan, Ashim Sarma, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24232AS1946PTC000653
- Company No.
000653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 1946
- Date of AGM
08 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Assam Chemical & Pharmaceutical Pvt Ltd offer?
Assam Chemical & Pharmaceutical Pvt Ltd offers a wide range of products and services, including Allopathic Cough Syrup, Corex Cough Syrup.
Who are the key members and board of directors at Assam Chemical & Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bimal Sarma  | Managing Director | 30-Jan-2010 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhab Das | Director | 11-Aug-2014 | Current |
| Jaydeep Bhuyan | Director | 29-Jun-2018 | Current |
| Ashim Sarma | Director | 30-Mar-2011 | Current |
| Anup Deka | Director | 13-Aug-2010 | Current |
| Ajay Singh | Director | 10-Sep-2012 | Current |
Financial Performance of Assam Chemical & Pharmaceutical.
Assam Chemical & Pharmaceutical Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 14.65% increase. The company also saw a substantial improvement in profitability, with a 24.26% increase in profit. The company's net worth Soared by an impressive increase of 11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assam Chemical & Pharmaceutical?
In 2022, Assam Chemical & Pharmaceutical had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 29 Oct 2024 | ₹3.09 M | Open |
United Bank Of India Creation Date: 27 Mar 1987 | ₹0.35 M | Open |
The United Bank Of India Creation Date: 27 Mar 1987 | ₹0.35 M | Open |
How Many Employees Work at Assam Chemical & Pharmaceutical?
Unlock and access historical data on people associated with Assam Chemical & Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assam Chemical & Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assam Chemical & Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
